Hetrombopag Olamine Tablets
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Hetrombopag Olamine Tablets, covering 2023-09-28 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer [Phase 2]